Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00685295 · ClinicalTrials.gov registry record · Phase 1
Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain
A Phase 1 study of Pain, Fracture, Sprain, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT00685295 is a Phase 1 study of Pain, Fracture, Sprain that has completed, run by Massachusetts General Hospital. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00685295, a Phase 1 study of Pain, Fracture, Sprain, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
Assess whether transbuccal fentanyl provides more rapid relief of orthopedic pain, than does the comparator Percocet
Conditions Studied
Interventions
- DRUG Oxycodone
- DRUG Fentanyl
- DRUG Lansoprazole
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00685295
The ClinicalTrials.gov registry entry for NCT00685295 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pain, Fracture, Sprain appearing as the primary indexed condition, and to 3 interventions - of which Oxycodone is the first listed.
NCT00685295 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00685295 about?
NCT00685295 is a clinical study titled "Fentanyl Administered Intraorally for Rapid Treatment of Orthopedic Pain". Assess whether transbuccal fentanyl provides more rapid relief of orthopedic pain, than does the comparator Percocet
What is the current status of trial NCT00685295?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2008-08. Estimated completion is 2009-02.
What conditions does trial NCT00685295 study?
This clinical trial studies the following conditions: Pain, Fracture, Sprain.
What interventions are being tested in trial NCT00685295?
The interventions under investigation include: Oxycodone (DRUG), Fentanyl (DRUG), Lansoprazole (DRUG).
Who is sponsoring clinical trial NCT00685295?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00685295 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.